Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Bladder Cancer Recurrence Surveillance

NCT00903240 is registered in ClinicalTrials.gov with Predictive Biosciences as lead sponsor.

NCT NCT00903240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00903240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Bladder Cancer Recurrence Surveillance
Lead sponsor
Predictive Biosciences
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
October 31, 2010
Enrollment
1,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer recurrence